Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitrectomy | 66 | 2024 | 391 | 12.160 |
Why?
|
Retinal Detachment | 56 | 2024 | 428 | 10.650 |
Why?
|
Endophthalmitis | 25 | 2024 | 260 | 7.270 |
Why?
|
Visual Acuity | 88 | 2024 | 2662 | 6.030 |
Why?
|
Retinal Perforations | 26 | 2022 | 138 | 5.570 |
Why?
|
Eye Injuries, Penetrating | 13 | 2024 | 124 | 5.140 |
Why?
|
Retinal Diseases | 19 | 2023 | 704 | 3.720 |
Why?
|
Epiretinal Membrane | 15 | 2024 | 73 | 3.620 |
Why?
|
Vitreous Body | 18 | 2022 | 399 | 3.460 |
Why?
|
Vitreoretinopathy, Proliferative | 11 | 2024 | 76 | 3.330 |
Why?
|
Eye Foreign Bodies | 9 | 2024 | 52 | 3.290 |
Why?
|
Scleral Buckling | 19 | 2024 | 95 | 2.610 |
Why?
|
Diabetic Retinopathy | 25 | 2023 | 1275 | 2.480 |
Why?
|
Fluorescein Angiography | 35 | 2024 | 1051 | 2.480 |
Why?
|
Macular Edema | 16 | 2023 | 374 | 2.370 |
Why?
|
Intravitreal Injections | 24 | 2023 | 385 | 2.290 |
Why?
|
Tomography, Optical Coherence | 49 | 2024 | 2907 | 2.220 |
Why?
|
Eye Infections, Fungal | 5 | 2018 | 100 | 2.220 |
Why?
|
Retina | 30 | 2023 | 2652 | 2.180 |
Why?
|
Retinal Pigment Epithelium | 9 | 2017 | 303 | 2.160 |
Why?
|
Eye Infections, Bacterial | 9 | 2024 | 242 | 2.040 |
Why?
|
Choroid Diseases | 7 | 2016 | 63 | 2.020 |
Why?
|
Choroid | 8 | 2019 | 352 | 2.000 |
Why?
|
Vitreous Hemorrhage | 6 | 2024 | 48 | 1.920 |
Why?
|
Retinal Vein Occlusion | 9 | 2018 | 149 | 1.780 |
Why?
|
Ophthalmologic Surgical Procedures | 6 | 2024 | 356 | 1.730 |
Why?
|
Angiogenesis Inhibitors | 19 | 2023 | 2047 | 1.590 |
Why?
|
Eye Injuries | 8 | 2019 | 227 | 1.580 |
Why?
|
Retinal Hemorrhage | 7 | 2020 | 95 | 1.460 |
Why?
|
Endotamponade | 8 | 2021 | 37 | 1.380 |
Why?
|
Subretinal Fluid | 2 | 2019 | 24 | 1.250 |
Why?
|
Vitreoretinal Surgery | 5 | 2021 | 28 | 1.130 |
Why?
|
Eye Diseases | 5 | 2017 | 655 | 1.130 |
Why?
|
Laser Coagulation | 8 | 2020 | 330 | 1.130 |
Why?
|
Central Serous Chorioretinopathy | 2 | 2017 | 27 | 1.120 |
Why?
|
Macular Degeneration | 10 | 2022 | 1005 | 1.080 |
Why?
|
Basement Membrane | 7 | 2020 | 348 | 1.030 |
Why?
|
Retinal Vessels | 12 | 2024 | 851 | 1.020 |
Why?
|
Silicone Oils | 4 | 2021 | 22 | 1.010 |
Why?
|
Retinal Vasculitis | 5 | 2017 | 46 | 0.970 |
Why?
|
Iodine | 2 | 2017 | 288 | 0.940 |
Why?
|
Vascular Endothelial Growth Factor A | 19 | 2023 | 3486 | 0.910 |
Why?
|
Macula Lutea | 5 | 2024 | 169 | 0.870 |
Why?
|
Optic Nerve Diseases | 2 | 2017 | 342 | 0.840 |
Why?
|
Fluorocarbons | 7 | 2018 | 491 | 0.800 |
Why?
|
Retinal Necrosis Syndrome, Acute | 1 | 2022 | 24 | 0.800 |
Why?
|
Vision, Monocular | 1 | 2022 | 71 | 0.790 |
Why?
|
Vision Disorders | 7 | 2022 | 1088 | 0.730 |
Why?
|
Postoperative Complications | 15 | 2022 | 15627 | 0.730 |
Why?
|
Fundus Oculi | 16 | 2024 | 548 | 0.720 |
Why?
|
Vision, Binocular | 1 | 2022 | 225 | 0.720 |
Why?
|
Cataract Extraction | 6 | 2022 | 466 | 0.690 |
Why?
|
Humans | 202 | 2024 | 760437 | 0.660 |
Why?
|
Optic Disk | 3 | 2020 | 421 | 0.660 |
Why?
|
Indicators and Reagents | 1 | 2020 | 462 | 0.640 |
Why?
|
Electric Injuries | 1 | 2018 | 24 | 0.640 |
Why?
|
Myopia, Degenerative | 1 | 2018 | 15 | 0.630 |
Why?
|
Aicardi Syndrome | 1 | 2018 | 16 | 0.630 |
Why?
|
Surgical Wound Infection | 3 | 2017 | 1525 | 0.620 |
Why?
|
Choroid Hemorrhage | 2 | 2017 | 6 | 0.620 |
Why?
|
Fibrinolysin | 2 | 2015 | 131 | 0.600 |
Why?
|
Drug Compounding | 1 | 2019 | 246 | 0.600 |
Why?
|
Sclera | 3 | 2017 | 190 | 0.600 |
Why?
|
Pseudallescheria | 1 | 2017 | 3 | 0.600 |
Why?
|
Blast Injuries | 3 | 2024 | 322 | 0.590 |
Why?
|
Coloring Agents | 2 | 2020 | 559 | 0.590 |
Why?
|
Lighting | 1 | 2020 | 211 | 0.590 |
Why?
|
Filtering Surgery | 1 | 2017 | 33 | 0.590 |
Why?
|
Hypersensitivity | 2 | 2017 | 1157 | 0.590 |
Why?
|
Middle Aged | 96 | 2024 | 220382 | 0.580 |
Why?
|
Glaucoma | 5 | 2022 | 1183 | 0.580 |
Why?
|
Retrospective Studies | 62 | 2024 | 80430 | 0.570 |
Why?
|
Choroidal Neovascularization | 3 | 2016 | 363 | 0.560 |
Why?
|
Hypertensive Retinopathy | 1 | 2016 | 4 | 0.540 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2224 | 0.540 |
Why?
|
Granuloma, Foreign-Body | 1 | 2016 | 42 | 0.540 |
Why?
|
Povidone-Iodine | 1 | 2016 | 55 | 0.530 |
Why?
|
Vancomycin | 3 | 2017 | 503 | 0.530 |
Why?
|
Drug Users | 1 | 2017 | 134 | 0.530 |
Why?
|
Male | 112 | 2024 | 360035 | 0.510 |
Why?
|
Cornea | 5 | 2022 | 1331 | 0.510 |
Why?
|
Retinal Neurons | 2 | 2014 | 66 | 0.510 |
Why?
|
Leukostasis | 1 | 2015 | 23 | 0.510 |
Why?
|
Angiomatosis | 1 | 2015 | 46 | 0.500 |
Why?
|
Endothelium, Corneal | 1 | 2018 | 215 | 0.500 |
Why?
|
Retinal Dystrophies | 1 | 2016 | 65 | 0.500 |
Why?
|
Anti-Bacterial Agents | 11 | 2022 | 7424 | 0.490 |
Why?
|
Geographic Atrophy | 1 | 2016 | 83 | 0.480 |
Why?
|
Prostheses and Implants | 5 | 2022 | 1272 | 0.480 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 53 | 0.480 |
Why?
|
Giant Cell Arteritis | 2 | 2016 | 306 | 0.480 |
Why?
|
Retinal Artery Occlusion | 3 | 2013 | 77 | 0.480 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 3 | 2024 | 359 | 0.470 |
Why?
|
Polyps | 1 | 2016 | 197 | 0.470 |
Why?
|
Temporal Arteries | 1 | 2015 | 154 | 0.470 |
Why?
|
Infarction | 1 | 2015 | 248 | 0.460 |
Why?
|
Leukocytosis | 1 | 2015 | 251 | 0.460 |
Why?
|
Retinal Neovascularization | 7 | 2021 | 288 | 0.450 |
Why?
|
Connective Tissue Growth Factor | 2 | 2019 | 92 | 0.450 |
Why?
|
Fibrin | 1 | 2016 | 505 | 0.450 |
Why?
|
Glucocorticoids | 7 | 2018 | 2163 | 0.440 |
Why?
|
Syphilis | 1 | 2016 | 243 | 0.440 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2013 | 42 | 0.440 |
Why?
|
Uveal Diseases | 1 | 2013 | 45 | 0.430 |
Why?
|
Retinoschisis | 2 | 2023 | 30 | 0.430 |
Why?
|
Ophthalmology | 2 | 2017 | 550 | 0.420 |
Why?
|
Basketball | 1 | 2013 | 46 | 0.420 |
Why?
|
Spironolactone | 1 | 2016 | 411 | 0.420 |
Why?
|
Blindness | 6 | 2016 | 584 | 0.420 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 640 | 0.410 |
Why?
|
Aged | 68 | 2024 | 168840 | 0.410 |
Why?
|
Corpus Striatum | 1 | 2018 | 1235 | 0.400 |
Why?
|
Female | 105 | 2024 | 391875 | 0.400 |
Why?
|
Tissue Plasminogen Activator | 1 | 2018 | 1163 | 0.400 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2022 | 664 | 0.400 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 319 | 0.390 |
Why?
|
Staphylococcal Infections | 2 | 2016 | 1409 | 0.390 |
Why?
|
Fluocinolone Acetonide | 1 | 2011 | 38 | 0.380 |
Why?
|
Air Bags | 1 | 2011 | 12 | 0.380 |
Why?
|
Exanthema | 1 | 2016 | 504 | 0.380 |
Why?
|
Anterior Chamber | 3 | 1998 | 194 | 0.380 |
Why?
|
Firearms | 1 | 2018 | 625 | 0.370 |
Why?
|
Aniridia | 1 | 2010 | 36 | 0.370 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1165 | 0.370 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1087 | 0.370 |
Why?
|
Aphakia | 1 | 2010 | 26 | 0.360 |
Why?
|
Disease Management | 2 | 2020 | 2501 | 0.360 |
Why?
|
Pseudophakia | 2 | 2021 | 60 | 0.360 |
Why?
|
Adult | 62 | 2024 | 220781 | 0.360 |
Why?
|
Follow-Up Studies | 32 | 2024 | 39078 | 0.360 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 685 | 0.350 |
Why?
|
Anterior Eye Segment | 2 | 2010 | 143 | 0.350 |
Why?
|
Bacteria | 2 | 2018 | 2217 | 0.340 |
Why?
|
Bioprosthesis | 1 | 2014 | 593 | 0.340 |
Why?
|
Choroid Neoplasms | 1 | 2011 | 177 | 0.340 |
Why?
|
Visual Prosthesis | 3 | 2016 | 48 | 0.340 |
Why?
|
Corneal Diseases | 3 | 2022 | 541 | 0.340 |
Why?
|
Iris | 1 | 2010 | 232 | 0.330 |
Why?
|
Klebsiella Infections | 1 | 2011 | 148 | 0.330 |
Why?
|
Polymers | 1 | 2017 | 1615 | 0.330 |
Why?
|
Melanocytes | 1 | 2013 | 509 | 0.330 |
Why?
|
Risk Assessment | 4 | 2021 | 23953 | 0.320 |
Why?
|
Klebsiella pneumoniae | 1 | 2011 | 256 | 0.320 |
Why?
|
Sutures | 1 | 2010 | 284 | 0.310 |
Why?
|
Fibrinolytic Agents | 2 | 2015 | 2082 | 0.310 |
Why?
|
Metals | 1 | 2013 | 716 | 0.310 |
Why?
|
Trabeculectomy | 2 | 2015 | 174 | 0.310 |
Why?
|
Lens Implantation, Intraocular | 4 | 2017 | 190 | 0.310 |
Why?
|
Fungi | 2 | 2018 | 338 | 0.300 |
Why?
|
Intraocular Pressure | 8 | 2020 | 1291 | 0.290 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 917 | 0.290 |
Why?
|
Cataract | 3 | 2022 | 831 | 0.280 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1598 | 0.280 |
Why?
|
Drug Implants | 3 | 2018 | 230 | 0.280 |
Why?
|
Skin Diseases | 1 | 2015 | 1090 | 0.270 |
Why?
|
Aged, 80 and over | 23 | 2024 | 58859 | 0.270 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1384 | 0.270 |
Why?
|
Suture Techniques | 2 | 2010 | 771 | 0.260 |
Why?
|
Microscopy, Acoustic | 2 | 2019 | 47 | 0.260 |
Why?
|
Recombinant Fusion Proteins | 4 | 2022 | 3734 | 0.250 |
Why?
|
Peptide Fragments | 2 | 2015 | 5105 | 0.250 |
Why?
|
Accidents, Traffic | 1 | 2011 | 816 | 0.250 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6330 | 0.250 |
Why?
|
Recurrence | 5 | 2019 | 8466 | 0.240 |
Why?
|
Urban Population | 1 | 2013 | 2032 | 0.240 |
Why?
|
Wounds, Nonpenetrating | 1 | 2011 | 807 | 0.230 |
Why?
|
Self Mutilation | 1 | 2004 | 57 | 0.230 |
Why?
|
Foreign-Body Migration | 2 | 1998 | 219 | 0.230 |
Why?
|
Receptors, Fibroblast Growth Factor | 2 | 2023 | 191 | 0.220 |
Why?
|
Risk Factors | 14 | 2024 | 74055 | 0.220 |
Why?
|
Exudates and Transudates | 3 | 2016 | 174 | 0.220 |
Why?
|
Antibodies, Monoclonal | 3 | 2010 | 9176 | 0.220 |
Why?
|
Trauma Severity Indices | 2 | 2017 | 478 | 0.220 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1365 | 0.220 |
Why?
|
Treatment Outcome | 29 | 2023 | 64591 | 0.220 |
Why?
|
Fovea Centralis | 2 | 2023 | 126 | 0.220 |
Why?
|
Retinitis Pigmentosa | 3 | 2016 | 397 | 0.220 |
Why?
|
Adolescent | 19 | 2024 | 88196 | 0.220 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2023 | 22 | 0.210 |
Why?
|
Young Adult | 14 | 2024 | 59068 | 0.210 |
Why?
|
Osteogenesis Imperfecta | 1 | 2003 | 81 | 0.210 |
Why?
|
Intraoperative Period | 2 | 2021 | 511 | 0.210 |
Why?
|
Aqueous Humor | 4 | 2013 | 153 | 0.200 |
Why?
|
Choroideremia | 1 | 2022 | 27 | 0.200 |
Why?
|
Injections | 4 | 2017 | 829 | 0.200 |
Why?
|
Eye Infections, Viral | 2 | 2020 | 60 | 0.200 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1580 | 0.190 |
Why?
|
Eisenmenger Complex | 1 | 2001 | 26 | 0.190 |
Why?
|
Time Factors | 10 | 2024 | 39947 | 0.190 |
Why?
|
Bacteremia | 2 | 2023 | 979 | 0.190 |
Why?
|
Candida | 1 | 2002 | 173 | 0.190 |
Why?
|
Retinal Degeneration | 2 | 2018 | 413 | 0.190 |
Why?
|
Tourette Syndrome | 1 | 2004 | 395 | 0.190 |
Why?
|
Prednisolone | 4 | 2015 | 326 | 0.180 |
Why?
|
Self Report | 3 | 2017 | 3721 | 0.180 |
Why?
|
Staphylococcus | 2 | 2016 | 156 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1646 | 0.180 |
Why?
|
Emulsions | 2 | 2020 | 153 | 0.180 |
Why?
|
Coxsackievirus Infections | 1 | 2020 | 42 | 0.180 |
Why?
|
Smoking | 1 | 2017 | 9046 | 0.180 |
Why?
|
Ophthalmoscopy | 2 | 2019 | 171 | 0.180 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2019 | 30 | 0.170 |
Why?
|
Enterovirus | 1 | 2020 | 67 | 0.170 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7996 | 0.170 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2022 | 343 | 0.160 |
Why?
|
Myopia | 1 | 2021 | 251 | 0.160 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 2018 | 77 | 0.160 |
Why?
|
Contact Lenses | 1 | 2020 | 138 | 0.160 |
Why?
|
Child, Preschool | 8 | 2024 | 42209 | 0.160 |
Why?
|
Retinal Telangiectasis | 1 | 2018 | 25 | 0.160 |
Why?
|
Quinoxalines | 1 | 2020 | 296 | 0.160 |
Why?
|
Administration, Oral | 3 | 2016 | 4010 | 0.150 |
Why?
|
Postoperative Period | 2 | 2020 | 1807 | 0.150 |
Why?
|
Silicone Elastomers | 2 | 1999 | 78 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3541 | 0.150 |
Why?
|
Haemophilus Infections | 1 | 1998 | 95 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2002 | 530 | 0.150 |
Why?
|
Coloboma | 1 | 2018 | 59 | 0.150 |
Why?
|
Haemophilus influenzae | 1 | 1998 | 180 | 0.140 |
Why?
|
Prospective Studies | 19 | 2022 | 54339 | 0.140 |
Why?
|
Incidence | 6 | 2021 | 21322 | 0.140 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5835 | 0.140 |
Why?
|
Drug Therapy, Combination | 7 | 2015 | 6297 | 0.140 |
Why?
|
Ultrasonography | 4 | 2019 | 5966 | 0.140 |
Why?
|
Syphilis Serodiagnosis | 1 | 2016 | 37 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 7 | 2019 | 20551 | 0.140 |
Why?
|
Laser Therapy | 2 | 2020 | 1092 | 0.130 |
Why?
|
Pigment Epithelium of Eye | 2 | 1997 | 209 | 0.130 |
Why?
|
Phacoemulsification | 2 | 1997 | 149 | 0.130 |
Why?
|
Graves Ophthalmopathy | 1 | 2018 | 133 | 0.130 |
Why?
|
Case-Control Studies | 4 | 2019 | 22097 | 0.130 |
Why?
|
Adrenergic beta-Agonists | 1 | 1997 | 344 | 0.130 |
Why?
|
European Union | 1 | 2017 | 157 | 0.130 |
Why?
|
Fusarium | 2 | 2006 | 51 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 736 | 0.130 |
Why?
|
Retinal Drusen | 1 | 2016 | 74 | 0.130 |
Why?
|
Prosthesis Implantation | 2 | 2022 | 592 | 0.130 |
Why?
|
Ocular Hypertension | 3 | 2002 | 208 | 0.130 |
Why?
|
Visually Impaired Persons | 1 | 2016 | 78 | 0.130 |
Why?
|
Massachusetts | 3 | 2017 | 8826 | 0.130 |
Why?
|
Liposomes | 1 | 2019 | 781 | 0.120 |
Why?
|
Phospholipids | 1 | 2019 | 786 | 0.120 |
Why?
|
Moraxellaceae Infections | 1 | 2015 | 7 | 0.120 |
Why?
|
Glaucoma, Neovascular | 1 | 2015 | 36 | 0.120 |
Why?
|
Microsurgery | 2 | 2011 | 795 | 0.120 |
Why?
|
Methotrexate | 2 | 2023 | 1720 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29551 | 0.120 |
Why?
|
Device Approval | 1 | 2017 | 163 | 0.120 |
Why?
|
Collagen Diseases | 1 | 2015 | 39 | 0.120 |
Why?
|
Vitreous Detachment | 1 | 2015 | 22 | 0.120 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8522 | 0.120 |
Why?
|
Double-Blind Method | 3 | 2015 | 12320 | 0.120 |
Why?
|
Military Personnel | 1 | 2024 | 1246 | 0.120 |
Why?
|
New England | 1 | 2017 | 1052 | 0.120 |
Why?
|
Rabbits | 3 | 2024 | 4780 | 0.120 |
Why?
|
Atrophy | 3 | 2023 | 1631 | 0.120 |
Why?
|
Diagnosis, Differential | 5 | 2018 | 12969 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 36362 | 0.120 |
Why?
|
Aptamers, Nucleotide | 1 | 2015 | 165 | 0.120 |
Why?
|
Drug Substitution | 2 | 2015 | 288 | 0.110 |
Why?
|
Haiti | 1 | 2016 | 550 | 0.110 |
Why?
|
Organ Size | 1 | 2019 | 2252 | 0.110 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 240 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1567 | 0.110 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 56 | 0.110 |
Why?
|
Polymerase Chain Reaction | 4 | 2015 | 6086 | 0.110 |
Why?
|
Optic Atrophies, Hereditary | 1 | 1993 | 27 | 0.110 |
Why?
|
Arthritis, Psoriatic | 1 | 2016 | 219 | 0.110 |
Why?
|
Vision, Low | 1 | 2015 | 163 | 0.110 |
Why?
|
Lenses, Intraocular | 4 | 1999 | 138 | 0.110 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3439 | 0.110 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2015 | 618 | 0.110 |
Why?
|
Child | 10 | 2024 | 80086 | 0.110 |
Why?
|
Sclerostomy | 3 | 2012 | 16 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2024 | 18216 | 0.100 |
Why?
|
HIV Seronegativity | 1 | 2013 | 211 | 0.100 |
Why?
|
Mycoses | 2 | 2006 | 386 | 0.100 |
Why?
|
Explosions | 1 | 2013 | 108 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2024 | 10425 | 0.100 |
Why?
|
Uveitis | 1 | 2016 | 395 | 0.100 |
Why?
|
Hearing Loss, Sensorineural | 2 | 2015 | 781 | 0.100 |
Why?
|
Ischemia | 3 | 2023 | 1876 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 1007 | 0.100 |
Why?
|
Eye Infections | 1 | 2012 | 62 | 0.100 |
Why?
|
Michigan | 1 | 2013 | 339 | 0.100 |
Why?
|
Nanoparticles | 2 | 2024 | 1953 | 0.100 |
Why?
|
Neck Pain | 1 | 2013 | 188 | 0.100 |
Why?
|
Neck Injuries | 1 | 2013 | 160 | 0.100 |
Why?
|
Sulfur Hexafluoride | 1 | 2011 | 26 | 0.100 |
Why?
|
Trochlear Nerve | 1 | 1991 | 26 | 0.100 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2014 | 367 | 0.100 |
Why?
|
Mass Casualty Incidents | 1 | 2014 | 179 | 0.100 |
Why?
|
Connective Tissue Diseases | 1 | 2015 | 285 | 0.100 |
Why?
|
History, 20th Century | 1 | 2020 | 2770 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2024 | 12785 | 0.100 |
Why?
|
Tachyphylaxis | 1 | 2011 | 54 | 0.100 |
Why?
|
Fourier Analysis | 1 | 2012 | 441 | 0.100 |
Why?
|
Pupil Disorders | 1 | 1991 | 32 | 0.100 |
Why?
|
Listeriosis | 1 | 1992 | 150 | 0.100 |
Why?
|
Catheterization | 1 | 2017 | 1432 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2015 | 1596 | 0.090 |
Why?
|
ROC Curve | 1 | 2019 | 3571 | 0.090 |
Why?
|
Rupture | 1 | 2013 | 443 | 0.090 |
Why?
|
Electrodes, Implanted | 2 | 2015 | 839 | 0.090 |
Why?
|
Prolapse | 1 | 2010 | 63 | 0.090 |
Why?
|
Infrared Rays | 1 | 2012 | 247 | 0.090 |
Why?
|
Wet Macular Degeneration | 1 | 2013 | 162 | 0.090 |
Why?
|
Polypropylenes | 1 | 2010 | 63 | 0.090 |
Why?
|
Dexamethasone | 1 | 2018 | 1944 | 0.090 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2946 | 0.090 |
Why?
|
Serotyping | 1 | 2011 | 326 | 0.090 |
Why?
|
Bacterial Typing Techniques | 1 | 2011 | 264 | 0.090 |
Why?
|
Copper | 1 | 2013 | 368 | 0.090 |
Why?
|
Fatal Outcome | 2 | 2013 | 1832 | 0.090 |
Why?
|
Brain Abscess | 1 | 2011 | 120 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 2007 | 0.090 |
Why?
|
Paralysis | 1 | 1991 | 250 | 0.090 |
Why?
|
Photochemotherapy | 1 | 2016 | 823 | 0.080 |
Why?
|
Mesencephalon | 1 | 1991 | 332 | 0.080 |
Why?
|
Disease Progression | 4 | 2015 | 13484 | 0.080 |
Why?
|
Nephritis, Hereditary | 1 | 2009 | 78 | 0.080 |
Why?
|
Arthritis | 1 | 2015 | 682 | 0.080 |
Why?
|
Hyperlipidemias | 1 | 2014 | 771 | 0.080 |
Why?
|
Oculomotor Muscles | 1 | 1993 | 407 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 621 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 781 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 834 | 0.080 |
Why?
|
Fibrosis | 3 | 2019 | 2048 | 0.080 |
Why?
|
Eye Diseases, Hereditary | 1 | 2009 | 122 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1762 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26063 | 0.080 |
Why?
|
Scotoma | 1 | 2009 | 130 | 0.070 |
Why?
|
Acute Disease | 4 | 2012 | 7230 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2021 | 1918 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1262 | 0.070 |
Why?
|
Astrocytoma | 1 | 1991 | 775 | 0.070 |
Why?
|
Endocarditis, Bacterial | 1 | 2011 | 444 | 0.070 |
Why?
|
Functional Laterality | 2 | 2011 | 2253 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1649 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4063 | 0.070 |
Why?
|
Medicine | 1 | 2014 | 941 | 0.070 |
Why?
|
Retinopathy of Prematurity | 2 | 2005 | 439 | 0.070 |
Why?
|
Cryosurgery | 1 | 2011 | 473 | 0.060 |
Why?
|
Electric Stimulation Therapy | 1 | 2012 | 626 | 0.060 |
Why?
|
Apoptosis | 2 | 2019 | 9468 | 0.060 |
Why?
|
Headache | 1 | 2013 | 1252 | 0.060 |
Why?
|
Paclitaxel | 1 | 2013 | 1732 | 0.060 |
Why?
|
Conjunctiva | 1 | 2009 | 479 | 0.060 |
Why?
|
Video Recording | 1 | 2010 | 962 | 0.060 |
Why?
|
Clinical Competence | 1 | 2021 | 4777 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3800 | 0.060 |
Why?
|
Infant | 5 | 2018 | 36183 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 643 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1245 | 0.060 |
Why?
|
Fungemia | 1 | 2005 | 57 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12653 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20078 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4168 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2665 | 0.060 |
Why?
|
Iron | 1 | 2013 | 1787 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2017 | 3541 | 0.060 |
Why?
|
Endothelial Growth Factors | 2 | 1997 | 673 | 0.060 |
Why?
|
United States | 5 | 2024 | 72202 | 0.060 |
Why?
|
Streptococcus anginosus | 1 | 2023 | 24 | 0.060 |
Why?
|
Fluorouracil | 1 | 2009 | 1637 | 0.060 |
Why?
|
Actins | 3 | 2019 | 2049 | 0.060 |
Why?
|
Biopsy | 1 | 2015 | 6765 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 3 | 2015 | 552 | 0.060 |
Why?
|
Lymphokines | 2 | 1997 | 927 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1385 | 0.050 |
Why?
|
Phenylephrine | 1 | 2004 | 293 | 0.050 |
Why?
|
Epistaxis | 1 | 2004 | 111 | 0.050 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2004 | 177 | 0.050 |
Why?
|
Ciliary Body | 2 | 2021 | 167 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2018 | 1571 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6471 | 0.050 |
Why?
|
Pancreatitis, Chronic | 1 | 2006 | 281 | 0.050 |
Why?
|
Survival Rate | 1 | 2017 | 12698 | 0.050 |
Why?
|
Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11900 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Microelectrodes | 2 | 2015 | 306 | 0.050 |
Why?
|
Hypergammaglobulinemia | 1 | 2002 | 72 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Panuveitis | 1 | 2002 | 33 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2003 | 312 | 0.050 |
Why?
|
Postoperative Care | 1 | 2009 | 1471 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3303 | 0.050 |
Why?
|
Propionibacterium acnes | 1 | 2022 | 65 | 0.050 |
Why?
|
Blood Viscosity | 1 | 2002 | 124 | 0.050 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2004 | 191 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2005 | 694 | 0.050 |
Why?
|
Nitrous Oxide | 1 | 2002 | 166 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2002 | 206 | 0.050 |
Why?
|
Ectodermal Dysplasia | 1 | 2002 | 106 | 0.050 |
Why?
|
Debridement | 1 | 2003 | 493 | 0.050 |
Why?
|
Epithelium, Corneal | 1 | 2003 | 252 | 0.050 |
Why?
|
Remission, Spontaneous | 1 | 2001 | 384 | 0.050 |
Why?
|
Cell Separation | 2 | 2017 | 1720 | 0.050 |
Why?
|
Phlebotomy | 1 | 2001 | 137 | 0.040 |
Why?
|
Pigmentation | 1 | 2021 | 144 | 0.040 |
Why?
|
Heart Septal Defects | 1 | 2001 | 191 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
Hematocrit | 1 | 2001 | 625 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2017 | 427 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2023 | 2642 | 0.040 |
Why?
|
Eye | 1 | 2023 | 710 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 12127 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2022 | 1992 | 0.040 |
Why?
|
DNA, Fungal | 1 | 2000 | 275 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 665 | 0.040 |
Why?
|
Acrylic Resins | 1 | 1999 | 135 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4106 | 0.040 |
Why?
|
Neuroglia | 2 | 2011 | 955 | 0.040 |
Why?
|
Ceftazidime | 1 | 1998 | 57 | 0.040 |
Why?
|
Polymethyl Methacrylate | 1 | 1999 | 131 | 0.040 |
Why?
|
Beclomethasone | 1 | 1997 | 38 | 0.040 |
Why?
|
Environment | 1 | 2024 | 1122 | 0.040 |
Why?
|
Oxygen | 2 | 2017 | 4222 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2799 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1997 | 591 | 0.040 |
Why?
|
Keratins | 1 | 2019 | 497 | 0.040 |
Why?
|
Anesthetics, Inhalation | 1 | 2002 | 574 | 0.040 |
Why?
|
Candidiasis | 1 | 2000 | 364 | 0.040 |
Why?
|
Microvessels | 1 | 2021 | 574 | 0.040 |
Why?
|
Dependovirus | 1 | 2022 | 715 | 0.040 |
Why?
|
Triamcinolone Acetonide | 1 | 1997 | 100 | 0.040 |
Why?
|
Candida albicans | 1 | 2000 | 372 | 0.030 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2018 | 203 | 0.030 |
Why?
|
Bronchitis | 1 | 1997 | 196 | 0.030 |
Why?
|
Cephalosporins | 1 | 1998 | 204 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11070 | 0.030 |
Why?
|
Albuterol | 1 | 1997 | 213 | 0.030 |
Why?
|
Electroretinography | 1 | 2018 | 521 | 0.030 |
Why?
|
Androstadienes | 1 | 1997 | 348 | 0.030 |
Why?
|
Betamethasone | 1 | 1995 | 49 | 0.030 |
Why?
|
Eye Abnormalities | 1 | 1998 | 241 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2002 | 1173 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2878 | 0.030 |
Why?
|
Cell Movement | 2 | 2017 | 5198 | 0.030 |
Why?
|
Visual Perception | 2 | 2012 | 1379 | 0.030 |
Why?
|
Angiopoietin-1 | 1 | 2015 | 122 | 0.030 |
Why?
|
Drainage | 1 | 2020 | 1155 | 0.030 |
Why?
|
Reading | 1 | 2018 | 529 | 0.030 |
Why?
|
Genetic Loci | 1 | 2024 | 2626 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1998 | 460 | 0.030 |
Why?
|
Blister | 1 | 2015 | 86 | 0.030 |
Why?
|
Chronic Disease | 3 | 2014 | 9309 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1156 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8527 | 0.030 |
Why?
|
Foscarnet | 1 | 2013 | 35 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13616 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
Bombs | 1 | 2014 | 73 | 0.030 |
Why?
|
Glaucoma Drainage Implants | 1 | 2015 | 106 | 0.030 |
Why?
|
Uveitis, Posterior | 1 | 2013 | 45 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 2860 | 0.030 |
Why?
|
Optic Nerve | 1 | 1997 | 572 | 0.030 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 828 | 0.030 |
Why?
|
Texas | 1 | 2014 | 404 | 0.030 |
Why?
|
Ganciclovir | 1 | 2013 | 252 | 0.030 |
Why?
|
Optic Atrophy | 1 | 1993 | 79 | 0.030 |
Why?
|
Suppuration | 1 | 1992 | 61 | 0.030 |
Why?
|
Perioperative Period | 1 | 2014 | 249 | 0.030 |
Why?
|
Social Support | 1 | 2023 | 2167 | 0.030 |
Why?
|
Equipment Design | 1 | 2020 | 3510 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 1995 | 512 | 0.020 |
Why?
|
Keratin-8 | 1 | 2011 | 11 | 0.020 |
Why?
|
Scleritis | 1 | 1992 | 96 | 0.020 |
Why?
|
Chickenpox | 1 | 1992 | 96 | 0.020 |
Why?
|
Visual Fields | 1 | 2018 | 1055 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1995 | 454 | 0.020 |
Why?
|
Keratin-18 | 1 | 2011 | 38 | 0.020 |
Why?
|
Animals | 4 | 2024 | 168253 | 0.020 |
Why?
|
Corneal Stroma | 1 | 1992 | 171 | 0.020 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3155 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 1991 | 113 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2006 | 3610 | 0.020 |
Why?
|
Hypertrophy | 1 | 2012 | 559 | 0.020 |
Why?
|
Listeria monocytogenes | 1 | 1992 | 250 | 0.020 |
Why?
|
Sensory Thresholds | 1 | 2012 | 377 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1998 | 1422 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1428 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 1991 | 9003 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
Rhinitis | 1 | 1997 | 746 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17328 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18379 | 0.020 |
Why?
|
Pedigree | 2 | 1998 | 4586 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5236 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2009 | 208 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2642 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2115 | 0.020 |
Why?
|
Necrosis | 1 | 2013 | 1604 | 0.020 |
Why?
|
Keratitis | 1 | 1992 | 239 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2013 | 755 | 0.020 |
Why?
|
Pregnancy | 2 | 2016 | 29831 | 0.020 |
Why?
|
Retreatment | 1 | 2010 | 598 | 0.020 |
Why?
|
Prevalence | 2 | 2023 | 15698 | 0.020 |
Why?
|
Pain | 2 | 2019 | 5075 | 0.020 |
Why?
|
Hyperpigmentation | 1 | 2009 | 117 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2023 | 26280 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3159 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2569 | 0.020 |
Why?
|
Orientation | 1 | 2009 | 321 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 756 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2002 | 3759 | 0.020 |
Why?
|
DNA, Viral | 1 | 2013 | 2201 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 411 | 0.020 |
Why?
|
Locomotion | 1 | 2009 | 388 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4241 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4355 | 0.020 |
Why?
|
Amylases | 1 | 2006 | 169 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4342 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 1997 | 748 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1703 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15867 | 0.010 |
Why?
|
Lubrication | 1 | 2003 | 21 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81402 | 0.010 |
Why?
|
Syndrome | 2 | 2002 | 3267 | 0.010 |
Why?
|
Lipase | 1 | 2006 | 324 | 0.010 |
Why?
|
Immunoenzyme Techniques | 2 | 1997 | 1704 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10759 | 0.010 |
Why?
|
Corneal Edema | 1 | 2003 | 47 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10746 | 0.010 |
Why?
|
Viscosity | 1 | 2003 | 336 | 0.010 |
Why?
|
Reoperation | 1 | 1993 | 4300 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2006 | 505 | 0.010 |
Why?
|
Tropanes | 1 | 2002 | 48 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1317 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16585 | 0.010 |
Why?
|
Retinitis | 1 | 2002 | 36 | 0.010 |
Why?
|
Parasympatholytics | 1 | 2002 | 89 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2005 | 386 | 0.010 |
Why?
|
Ophthalmic Artery | 1 | 2002 | 58 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 17854 | 0.010 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2005 | 406 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 2004 | 477 | 0.010 |
Why?
|
Photophobia | 1 | 2002 | 75 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2006 | 855 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9326 | 0.010 |
Why?
|
Papilledema | 1 | 2002 | 130 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9462 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2013 | 3066 | 0.010 |
Why?
|
Methylprednisolone | 1 | 2002 | 384 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2016 | 3407 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18955 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 41366 | 0.010 |
Why?
|
Pancreatitis | 1 | 2006 | 1096 | 0.010 |
Why?
|
Asthma | 1 | 1997 | 6195 | 0.010 |
Why?
|
Vasculitis | 1 | 2002 | 522 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2217 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 1999 | 461 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11526 | 0.010 |
Why?
|
Birth Weight | 1 | 2005 | 2098 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1999 | 944 | 0.010 |
Why?
|
Membranes | 1 | 1996 | 165 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3574 | 0.010 |
Why?
|
Vimentin | 1 | 1997 | 255 | 0.010 |
Why?
|
Light Coagulation | 1 | 1995 | 71 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10538 | 0.010 |
Why?
|
Species Specificity | 1 | 2000 | 2417 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1055 | 0.010 |
Why?
|
Factor VIII | 1 | 1997 | 349 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2004 | 2018 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 13338 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 1999 | 1433 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 1999 | 860 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1995 | 961 | 0.010 |
Why?
|
Herpesvirus 3, Human | 1 | 1992 | 159 | 0.010 |
Why?
|
Lens Subluxation | 1 | 1991 | 23 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1995 | 14565 | 0.000 |
Why?
|